This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aflac Incorporated was formed in 1973 under the laws of the state of Georgia. The company is a general business holding company and oversees the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States (Aflac U.S.) and, effective Apr 1, 2018, through Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan).
Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?
by Zacks Equity Research
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.
Applied Digital's Q4 Earnings & Revenues Meet Estimates, Stock Up
by Zacks Equity Research
APLD's fiscal Q4 revenues rose 41%, and major CoreWeave contracts helped drive a sharp pre-market stock rally.
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gear Up for Aflac (AFL) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Unum (UNM) Lags Q2 Earnings Estimates
by Zacks Equity Research
Unum (UNM) delivered earnings and revenue surprises of -7.17% and +1.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Aflac (AFL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
by Zacks Equity Research
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Do Options Traders Know Something About Aflac Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to AFL stock based on the movements in the options market lately.
UNM Outperforms Industry, Trades at a Premium: Should You Buy the Stock?
by Zacks Equity Research
Unum Group outperforms in 2025 as core segments expand and the stock trades at a discount to the industry average.
GL Stock Trading at a Discount to Industry at 8.22X: Time to Hold?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFE
by Zacks Equity Research
AFL, UNM, TRUP, GL and AMSF are poised to gain from rising exposure and tech adoption despite pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
by Tanuka De
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.
UNM Stock Trading at a Discount to Industry at 1.23X: Time to Hold?
by Zacks Equity Research
Unum Group stock rallies on improved premium income, higher sales, strong persistency, favorable benefits experience, as well as effective capital deployment.
Seeking a Payday? 3 Dividend Kings Worth a Look: PM, AFL, EMR
by Derek Lewis
These companies have shown incredible resilience historically, surviving through many economic periods while also continuously increasingly rewarding shareholders.
GL Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Globe Life gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
Aflac (AFL) Down 0.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aflac Q1 Earnings Miss Estimates on Lower Japan Premiums
by Zacks Equity Research
AFL continues to witness growth in U.S. segment revenues. It returns $900 million to shareholders in the first quarter via share buybacks.
Aflac (AFL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Aflac (AFL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Aflac (AFL) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of -1.19% and 1.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Unum (UNM) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Unum (UNM) delivered earnings and revenue surprises of -6.85% and 1.05%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Aflac Gears Up for Q1 Earnings: Will AFL Quack or Crack?
by Zacks Equity Research
AFL's first-quarter earnings are likely to have benefited from growing total adjusted revenues in Aflac U.S.
What to Expect From These 4 Insurers This Earnings Season?
by Debasmita Chatterjee
Strong premiums, M&A activities and tech efficiencies are likely to have aided insurers' Q1 performance, despite pressure from low interest rates, inflationary headwinds and catastrophe-related losses.
Insights Into Aflac (AFL) Q1: Wall Street Projections for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Aflac (AFL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.